beta-Amyloid (25-35) or substance P stimulates [3H]MK-801 binding to rat cortical membranes in the presence of glutamate and glycine

J Neurochem. 1993 Jun;60(6):2297-303. doi: 10.1111/j.1471-4159.1993.tb03517.x.

Abstract

Micromolar concentrations of beta-amyloid (25-35) or substance P stimulated [3H]MK-801 binding in the presence of low concentrations of glutamate (1 microM) and glycine (0.02 microM). Unlike polyamines spermine and spermidine, neither beta-amyloid (25-35) nor substance P increased [3H]MK-801 binding in the presence of maximally stimulating concentrations of glutamate and glycine. 5,7-Dichloro-kynurenic acid, CGS-19755, and arcaine completely inhibited the stimulated [3H]MK-801 binding. There was an apparent decreased potency of the [3H]MK-801 binding inhibition curve for 5,7-dichlorokynurenic acid, but not CGS-19755 or arcaine, in the presence of either beta-amyloid (25-35) or substance P. The compounds do not appear to act through the strychnine-insensitive glycine binding site because neither beta-amyloid (25-35) nor substance P displaced [3H]glycine binding. Full-length beta-amyloid (1-40), up to 10 microM, did not stimulate [3H]MK-801 binding. Concentrations > 10 microM could not be tested because they formed large aggregate precipitates in the assay. The data indicate that beta-amyloid (25-35) or substance P does not stimulate [3H]MK-801 binding at either the N-methyl-D-aspartate, glycine, or polyamine binding sites. Furthermore, the nonpeptide substance P receptor (NK1) antagonist, CP-96,345, did not block beta-amyloid (25-35)- or substance P-stimulated [3H]MK-801 binding. Therefore, the effect is not due to an interaction between the substance P receptors and the N-methyl-D-aspartate receptor-operated ionophore. Finally, if these observations can be verified using single-channel recording techniques, they may have implications in the pattern of selective neuronal loss observed in patients with neurodegenerative processes such as Alzheimer's, Parkinson's, and Huntington's diseases.

MeSH terms

  • Amino Acid Sequence
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Biguanides / pharmacology
  • Cell Membrane / metabolism
  • Cerebral Cortex / metabolism*
  • Dizocilpine Maleate / metabolism*
  • Glutamates / pharmacology*
  • Glutamic Acid
  • Glycine / metabolism
  • Glycine / pharmacology*
  • Kinetics
  • Molecular Sequence Data
  • N-Methylaspartate / antagonists & inhibitors
  • Peptide Fragments / pharmacology*
  • Pipecolic Acids / pharmacology
  • Rats
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Sequence Homology, Amino Acid
  • Substance P / pharmacology*

Substances

  • Amyloid beta-Peptides
  • Biguanides
  • Glutamates
  • Peptide Fragments
  • Pipecolic Acids
  • Receptors, N-Methyl-D-Aspartate
  • amyloid beta-protein (25-35)
  • Substance P
  • Glutamic Acid
  • selfotel
  • arcaine
  • N-Methylaspartate
  • Dizocilpine Maleate
  • Glycine